NCT05500859Recruiting
Swiss Secondary Prevention and Rehabilitation Registry
Swiss Secondary Prevention and Rehabilitation Registry: SwissPR
Source: ClinicalTrials.gov · Last updated 22 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The SwissPR study is to continuously monitor patient characteristics and short- and long-term benchmark quality measures and outcomes of patients participating in a 12-week ambulatory CR program.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 8 Aug 2022
- Start date
- 20 Dec 2019
- Primary completion date
- Dec 2035
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Coronary artery disease
- NCT number
- NCT05500859
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 20 Dec 2019 to the primary completion date, Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to follow an ambulatory CR program more than 3 weeks
- Not willing to give informed consent
- Inability to understand the informed consent due to language comprehension
- Lack of discernment
Who the study is looking for
- Participation in an ambulatory CR program (all age groups)
- Written informed consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Basel, Division of Outpatient Cardiology Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.